Skip to main content

Lineage Cell Therapeutics, Inc.

LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000876343

No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Lineage Cell Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
116
+3 vs. Q4 2023
Shares held
93.4M
+17.7M (+23.4%) vs. Q4 2023
Total value
$138.3M
+$55.7M (+67.6%) vs. Q4 2023
New holders
15
29 more added
Sold out
12
32 more reduced

2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 116 institutions
Q1 2021: 102 institutionsQ2 2021: 115 institutionsQ3 2021: 115 institutionsQ4 2021: 124 institutionsQ1 2022: 109 institutionsQ2 2022: 100 institutionsQ3 2022: 104 institutionsQ4 2022: 106 institutionsQ1 2023: 116 institutionsQ2 2023: 107 institutionsQ3 2023: 104 institutionsQ4 2023: 115 institutionsQ1 2024: 116 institutionsQ2 2024: 113 institutionsQ3 2024: 114 institutionsQ4 2024: 126 institutionsQ1 2025: 127 institutionsQ2 2025: 129 institutionsQ3 2025: 112 institutionsQ4 2025: 123 institutionsQ1 2026: 130 institutionsQ2 2026: 131 institutions
Value heldQ1 2024: $138.3M
Q1 2021: $141.8MQ2 2021: $208.5MQ3 2021: $191.7MQ4 2021: $182.0MQ1 2022: $112.3MQ2 2022: $102.7MQ3 2022: $73.1MQ4 2022: $76.2MQ1 2023: $104.7MQ2 2023: $106.6MQ3 2023: $89.1MQ4 2023: $82.5MQ1 2024: $138.3MQ2 2024: $94.2MQ3 2024: $85.6MQ4 2024: $53.8MQ1 2025: $49.7MQ2 2025: $88.4MQ3 2025: $148.6MQ4 2025: $169.8MQ1 2026: $176.5MQ2 2026: $152.7M
Institutions holding LCTX and their total value by quarter
QuarterHoldersValue
Q2 2026131$152.7M
Q1 2026130$176.5M
Q4 2025123$169.8M
Q3 2025112$148.6M
Q2 2025129$88.4M
Q1 2025127$49.7M
Q4 2024126$53.8M
Q3 2024114$85.6M
Q2 2024113$94.2M
Q1 2024116$138.3M
Q4 2023115$82.5M
Q3 2023104$89.1M
Q2 2023107$106.6M
Q1 2023116$104.7M
Q4 2022106$76.2M
Q3 2022104$73.1M
Q2 2022100$102.7M
Q1 2022109$112.3M
Q4 2021124$182.0M
Q3 2021115$191.7M
Q2 2021115$208.5M
Q1 2021102$141.8M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding LCTX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC530,600$785.0K0.00%+380,600+253.7%Added
JPMorgan Chase & Co675,704$1.00M0.00%−51,309−7.1%Reduced
Bridgeway Capital Management, LLC681,766$1.01M0.02%−100,000−12.8%Reduced
Northern Trust Corp1,232,546$1.82M0.00%+37,362+3.1%Added
Bank of America Corp1,311,281$1.94M0.00%+1,287,428+5,397.3%Added
DAFNA Capital Management LLC1,366,308$2.02M0.46%+1,366,308New
MAI Capital Management1,490,862$2.21M0.02%+687,017+85.5%Added
Prescott General Partners LLC1,851,851$2.74M0.15%00.0%Unchanged
State Street Corp2,177,209$3.22M0.00%+80,600+3.8%Added
Raffles Associates LP3,209,981$4.75M5.51%+1,078,360+50.6%Added
Geode Capital Management, LLC3,253,056$4.82M0.00%+317,245+10.8%Added
Defender Capital, LLC.4,967,675$7.35M2.50%−2,0000.0%Reduced
Logos Global Management LP6,250,000$9.25M0.97%+6,250,000New
Vanguard Group Inc8,373,771$12.4M0.00%−10,916−0.1%Reduced
BlackRock Inc.8,494,395$12.6M0.00%−37,103−0.4%Reduced
Broadwood Capital Inc41,666,255$61.7M4.63%+6,730,770+19.3%Added
Laurion Capital Management LP0$00.00%−433,748−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−36,970−100.0%Sold out
HRT Financial LP0$00.00%−35,923−100.0%Sold out
SG Americas Securities, LLC0$00.00%−30,889−100.0%Sold out
Cetera Advisor Networks LLC0$00.00%−30,628−100.0%Sold out
XTX Topco Ltd0$00.00%−27,037−100.0%Sold out
AE Wealth Management LLC0$00.00%−15,543−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−12,704−100.0%Sold out
Fisher Asset Management, LLC0$00.00%−10,000−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−180−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−20−100.0%Sold out
Focused Wealth Management, Inc0$00.00%−8−100.0%Sold out
Coppell Advisory Solutions LLC––––Not filed
Strategic Investment Solutions, Inc.––––Not filed